Economic costs of childhood stunting to the private sector in low- and middle-income countries.
Children
Costs
Economy
Low and middle income
Private sector
Stunting
Journal
EClinicalMedicine
ISSN: 2589-5370
Titre abrégé: EClinicalMedicine
Pays: England
ID NLM: 101733727
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
04
11
2021
revised:
01
02
2022
accepted:
09
02
2022
entrez:
21
3
2022
pubmed:
22
3
2022
medline:
22
3
2022
Statut:
epublish
Résumé
Stunting during childhood has long-term consequences on human capital, including decreased physical growth, and lower educational attainment, cognition, workforce productivity and wages. Previous research has quantified the costs of stunting to national economies however beyond a few single-country datasets there has been a limited number of which have used diverse datasets and have had a dedicated focus on the private sector, which employs nearly 90% of the workforce in many low- and middle-income countries (LMICs). We aimed to examine (i) the impact of childhood stunting on income loss of private sector workforce in LMICs; (ii) to quantify losses in sales to private firms in LMICs due to childhood stunting; and (iii) to estimate potential gains (benefit-cost ratios) if stunting levels are reduced in select high prevalence countries. This multiple-methods study engaged multi-disciplinary technical advisers, executed several literature reviews, used innovative statistical methods, and implemented health and labor economic models. We analyzed data from seven longitudinal datasets (up to 30+ years of follow-up; 1982-2016; Peru, Ethiopia, India, Vietnam, Philippines, Tanzania, Brazil), 108 private firm datasets (spanning 2008-2020), and many global datasets including Joint Malnutrition Estimates, and World Development Indicators to produce estimates for 120+ LMICs (with estimates up to 2021). We studied the impact of childhood stunting on adult cognition, education, and height as pathways to wages/productivity in adulthood. We employed cloud-based artificial intelligence (AI) platforms, and conducted comparative analyses using three analytic approaches: traditional frequentist statistics, Bayesian inferential statistics and machine learning. We employed labour and health economic models to estimate wage losses to the private sector worker and firm revenue losses due to stunting. We also estimated benefit-cost ratios for countries investing in nutrition-specific interventions to prevent stunting. Across 95 LMICs, childhood stunting costs the private sector at least US$135.4 billion in sales annually. Firms from countries in Latin America and the Caribbean and East Asia and Pacific regions had the greatest losses. Totals sales losses to the private sector accumulated to 0.01% to 1.2% of national GDP across countries. Sectors most affected by childhood stunting were manufacturing (non-metallic mineral, fabricated metal, other), garments and food sectors. Sale losses were highest for larger sized private firms. Across regions (representing 123 LMICs), US$700 million (Middle East and North Africa) to US$16.5 billion (East Asia and Pacific) monthly income was lost among private sector workers. Investing in stunting reduction interventions yields gains from US$2 to US$81 per $1 invested annually (or 100% to 8000% across countries). Across sectors, the highest returns were in elementary occupations (US$46) and the lowest were among agricultural workers (US$8). By gender, women incurred a higher income penalty from childhood stunting and earned less than men; due to their relatively higher earnings, the returns for investing in stunting reduction were consistently higher for men across most countries studied. Childhood stunting costs the private sector in LMICs billions of dollars in sales and earnings for the workforce annually. Returns to nutrition interventions show that there is an economic case to be made for investing in childhood nutrition, alongside a moral one for both the public and private sector. This research could be used to motivate strong public-private sector partnerships to invest in childhood undernutrition for benefits in the short and long-term.
Sections du résumé
Background
UNASSIGNED
Stunting during childhood has long-term consequences on human capital, including decreased physical growth, and lower educational attainment, cognition, workforce productivity and wages. Previous research has quantified the costs of stunting to national economies however beyond a few single-country datasets there has been a limited number of which have used diverse datasets and have had a dedicated focus on the private sector, which employs nearly 90% of the workforce in many low- and middle-income countries (LMICs). We aimed to examine (i) the impact of childhood stunting on income loss of private sector workforce in LMICs; (ii) to quantify losses in sales to private firms in LMICs due to childhood stunting; and (iii) to estimate potential gains (benefit-cost ratios) if stunting levels are reduced in select high prevalence countries.
Methods
UNASSIGNED
This multiple-methods study engaged multi-disciplinary technical advisers, executed several literature reviews, used innovative statistical methods, and implemented health and labor economic models. We analyzed data from seven longitudinal datasets (up to 30+ years of follow-up; 1982-2016; Peru, Ethiopia, India, Vietnam, Philippines, Tanzania, Brazil), 108 private firm datasets (spanning 2008-2020), and many global datasets including Joint Malnutrition Estimates, and World Development Indicators to produce estimates for 120+ LMICs (with estimates up to 2021). We studied the impact of childhood stunting on adult cognition, education, and height as pathways to wages/productivity in adulthood. We employed cloud-based artificial intelligence (AI) platforms, and conducted comparative analyses using three analytic approaches: traditional frequentist statistics, Bayesian inferential statistics and machine learning. We employed labour and health economic models to estimate wage losses to the private sector worker and firm revenue losses due to stunting. We also estimated benefit-cost ratios for countries investing in nutrition-specific interventions to prevent stunting.
Findings
UNASSIGNED
Across 95 LMICs, childhood stunting costs the private sector at least US$135.4 billion in sales annually. Firms from countries in Latin America and the Caribbean and East Asia and Pacific regions had the greatest losses. Totals sales losses to the private sector accumulated to 0.01% to 1.2% of national GDP across countries. Sectors most affected by childhood stunting were manufacturing (non-metallic mineral, fabricated metal, other), garments and food sectors. Sale losses were highest for larger sized private firms. Across regions (representing 123 LMICs), US$700 million (Middle East and North Africa) to US$16.5 billion (East Asia and Pacific) monthly income was lost among private sector workers. Investing in stunting reduction interventions yields gains from US$2 to US$81 per $1 invested annually (or 100% to 8000% across countries). Across sectors, the highest returns were in elementary occupations (US$46) and the lowest were among agricultural workers (US$8). By gender, women incurred a higher income penalty from childhood stunting and earned less than men; due to their relatively higher earnings, the returns for investing in stunting reduction were consistently higher for men across most countries studied.
Interpretation
UNASSIGNED
Childhood stunting costs the private sector in LMICs billions of dollars in sales and earnings for the workforce annually. Returns to nutrition interventions show that there is an economic case to be made for investing in childhood nutrition, alongside a moral one for both the public and private sector. This research could be used to motivate strong public-private sector partnerships to invest in childhood undernutrition for benefits in the short and long-term.
Identifiants
pubmed: 35308896
doi: 10.1016/j.eclinm.2022.101320
pii: S2589-5370(22)00050-5
pmc: PMC8927824
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101320Informations de copyright
© 2022 The Author(s).
Déclaration de conflit d'intérêts
Nikita Japra is a current employee of Patrick J. McGovern Foundation (funder) and former employee of Cloudera Foundation (funder). NJ served as the program officer for the grant that funded this work while employed by Cloudera Foundation/Patrick J. McGovern Foundation (funder). Kerri Wazny was an employee of The Power of Nutrition (funder) during the work.
Références
Lancet. 2013 Aug 10;382(9891):536-51
pubmed: 23746780
Econ Hum Biol. 2019 Aug;34:225-238
pubmed: 31003858
Am J Clin Nutr. 2021 Nov 2;114(Suppl 1):15S-42S
pubmed: 34590672
Plast Reconstr Surg. 2010 Dec;126(6):2234-2242
pubmed: 20697313
Matern Child Nutr. 2013 Sep;9 Suppl 2:27-45
pubmed: 24074316
Lancet Child Adolesc Health. 2021 May;5(5):367-384
pubmed: 33691083
Pediatrics. 2012 Jul;130(1):e1-7
pubmed: 22732170
Pediatrics. 2010 Dec;126(6):e1617-21
pubmed: 21059717
World Bank Res Obs. 2017 Feb;32(1):107-125
pubmed: 28845075
Health Policy Plan. 2017 Jun 1;32(5):657-668
pubmed: 28453717
Am J Clin Nutr. 2016 Jul;104(1):104-12
pubmed: 27357091
Emerg Themes Epidemiol. 2015 Sep 30;12:14
pubmed: 26425136
Nutrients. 2020 Jun 08;12(6):
pubmed: 32521620
Am J Clin Nutr. 2021 Nov 2;114(Suppl 1):3S-14S
pubmed: 34590696
Matern Child Nutr. 2013 Sep;9 Suppl 2:69-82
pubmed: 24074319
Am J Public Health. 2010 Jun;100(6):974-80
pubmed: 20395578
Lat Am Econ Rev. 2014 Dec;23(1):4
pubmed: 26550556
World Rev Nutr Diet. 2015;111:198-204
pubmed: 25418413
Pediatrics. 2015 May;135(5):e1266-75
pubmed: 25847806
J Am Dent Assoc. 2006 Oct;137 Suppl:32S-36S
pubmed: 17012734
Sex Reprod Healthc. 2020 Oct;25:100514
pubmed: 32315815
Lancet. 2008 Feb 2;371(9610):411-6
pubmed: 18242415
Am J Clin Nutr. 2020 Sep 14;112(Suppl 2):894S-904S
pubmed: 32692800
Econ Hum Biol. 2009 Mar;7(1):7-17
pubmed: 19261549
Am J Clin Nutr. 2013 Nov;98(5):1170-8
pubmed: 24004889
Nature. 2018 Apr 5;556(7699):19-22
pubmed: 29620753
Am J Hum Biol. 2010 May-Jun;22(3):353-9
pubmed: 19856426
J Appl Psychol. 2004 Jun;89(3):428-41
pubmed: 15161403
Lancet. 2013 Aug 3;382(9890):452-477
pubmed: 23746776
Bull World Health Organ. 2005 Oct;83(10):792-5
pubmed: 16283057
Int J Epidemiol. 2017 Aug 1;46(4):1171-1191
pubmed: 28379434
Econ Hum Biol. 2017 May;25:52-64
pubmed: 27843117
J Appl Psychol. 1994 Dec;79(6):909-17
pubmed: 7852208
Matern Child Nutr. 2011 Oct;7 Suppl 3:5-18
pubmed: 21929633
Lancet. 2014 Sep 6;384(9946):869-79
pubmed: 25209488
Adv Nutr. 2021 Feb 1;12(1):251-275
pubmed: 32970116
Global Health. 2010 May 28;6:10
pubmed: 20509876
Lancet Public Health. 2020 Sep;5(9):e460
pubmed: 32888438
PLoS Med. 2012;9(7):e1001252
pubmed: 22802732
Soc Sci Med. 2011 Jan;72(2):185-92
pubmed: 21146909